How did FTXH's Momentum indicator behave recently?

The Momentum Indicator moved above the 0 level on June 22, 2026. You may want to consider a long position or call options on FTXH as a result. In 67 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 75%.

What does a 3-day price advance indicate for FTXH?

Following a +2.65% 3-day Advance, the price is estimated to grow further. Considering data from situations where FTXH advanced for three days, in 242 of 301 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

FTXH

AS OF

Jun 23, 03:43 PM (EDT)

Price

$36.23

Change

+$0.39 (+1.09%)

Net Assets

34.03M

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

+Compare

FTXH

ETF ticker: NASDAQ

AS OF

Jun 23, 03:43 PM (EDT)

Price

$36.23

Change

+$0.39 (+1.09%)

Net Assets

34.03M

FTXH

ETF ticker: NASDAQ

PRICE

CHANGE

NET ASSETS

FTXH stock forecast, quote, news & analysis

Q: How does the Aroon Indicator reflect on FTXH's trend?

The Aroon Indicator entered an Uptrend today. In 208 of 274 cases where FTXH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 76%.

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of the Nasdaq US Smart Pharmaceuticals TM Index... Show more

Category: #Health

Get AI intraday signals

FTXH

Setup

Daily Signal:

Description

Gain/Loss:

A.I.Advisor

published price charts

Intraday

View AI-Driven Trading for FTXH

Interact to see
Advertisement

A.I.Advisor

a Summary for FTXH with price predictions

Jun 22, 2026

FTXH's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for FTXH turned positive on June 04, 2026. Looking at past instances where FTXH's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 22, 2026. You may want to consider a long position or call options on FTXH as a result. In of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

FTXH moved above its 50-day moving average on June 03, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where FTXH advanced for three days, in of 301 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 274 cases where FTXH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 67 cases where FTXH's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FTXH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

FTXH broke above its upper Bollinger Band on June 11, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor

published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Merck & Co (NYSE:MRK), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), Regeneron Pharmaceuticals (NASDAQ:REGN), ZOETIS (NYSE:ZTS).

Industry description

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of the Nasdaq US Smart Pharmaceuticals TM Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking. It is non-diversified.

Market Cap

The average market capitalization across the First Trust Nasdaq Pharmaceuticals ETF ETF is 61.45B. The market cap for tickers in the group ranges from 1.31B to 987.23B. LLY holds the highest valuation in this group at 987.23B. The lowest valued company is PRGO at 1.31B.

High and low price notable news

The average weekly price growth across all stocks in the First Trust Nasdaq Pharmaceuticals ETF ETF was 2%. For the same ETF, the average monthly price growth was 4%, and the average quarterly price growth was 8%. SRRK experienced the highest price growth at 13%, while PRGO experienced the biggest fall at -11%.

Volume

The average weekly volume growth across all stocks in the First Trust Nasdaq Pharmaceuticals ETF ETF was 13%. For the same stocks of the ETF, the average monthly volume growth was 50% and the average quarterly volume growth was 165%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 61

P/E Growth Rating: 58

Price Growth Rating: 46

SMR Rating: 65

Profit Risk Rating: 62

Seasonality Score: 38 (-100 ... +100)

View a ticker or compare two or three

Compare

FTXH

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I. Advisor

published General Information

General Information

Category Health

Profile

Details